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Parkinson disease (PD) is of unknown but
presumably multifactorial etiology. The main
impetus for the environmental causation the-
ory of PD came from the isolation of the
chemical compound MPTP (1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine) that was
associated with marked parkinsonism in four
young adults after using a Demerol derivative
intravenously (Langston et al. 1984).
Toxic substances can cause static or pro-
gressive damage. The distinction between
these two pathogenetic mechanisms is relevant
to understanding whether early environmental
risk factors play a role in the pathogenesis of
PD. MPTP produces both acute and progres-
sive cellular loss in the substantia nigra.
MPTP exposure at one point in time can be
responsible for a progressive clinical syndrome
with an intervening latent period.
The neuropathologic study of the brains
of three MPTP-exposed subjects showed
microglial activation with an ongoing inﬂam-
matory reaction 3–6 years after the toxic expo-
sure (Langston et al. 1999). In each case
neuropathologic examination of the brain
revealed depletion of pigmented neurons in
the substantia nigra but without Lewy bodies,
the pathologic hallmark of PD. These ﬁndings
indicate an active, ongoing neuronal loss, sug-
gesting that an event happening at a single
point in time may determine a slowly progres-
sive neurodegenerative process in the substan-
tia nigra (Langston et al. 1999). In monkeys
exposed to MPTP 5–14 years before death
and free from MPTP exposure for 3 years
before death, biopsy data showed reactive
microglia and extracellular melanin (McGeer
et al. 2003). The results of these two studies
demonstrate that toxic exposure many years
before the onset of clinical parkinsonism can
result in a progressive neuronal loss and a per-
manent inﬂammatory reaction in the brain of
patients with PD. Consistent with this model,
a brain injury could produce a progressive loss
of dopaminergic (DA) cells prenatally or early
in life. Subsequently, a second toxic insult or
normal aging could determine a selective neuro-
degenerative process in the substantia nigra
(Langston 1990).
Even if sporadic PD is a neurodegenera-
tive disorder that characteristically begins
after 50 years of age, the possibility that it
could be determined by the early life environ-
ment has been proposed in the past (Martyn
and Osmond 1995). In this review I focus on
published evidence from both experimental
and epidemiologic studies of a possible role of
early life environmental risk factors for PD.
Infections in Early Life
Inflammation has been proposed as one of
the possible pathogenetic mechanisms for PD
(McGeer et al. 2001). The proinﬂammatory
cytokine tumor necrosis factor-α (TNF-α)
kills DA neurons in vitro and is elevated in
the brains of patients with PD (Mogi et al.
1994). Intrauterine infection might lead to
nigral cell loss in the fetal brain and a subse-
quent decrease in DA neurons in the substan-
tia nigra secondary to inﬂammation. Bacterial
vaginosis during pregnancy is characterized
by the presence of lipopolysaccharide (LPS), a
bacteriotoxin that is an inducer of TNF-α
(Thorsen et al. 1998). These compounds are
increased in the chorioamniotic environment
of infected women and could interfere with
the normal development of DA neurons.
Ling et al. (2002) injected gravid female rats
intraperitoneally with LPS, and the newborn
rats were killed 3 weeks after birth. The pre-
natal exposure to LPS produced lesions that
were specific to DA cells. DA cells were
counted in the mesencephalon using tyrosine
hydroxylase–immunoreactive (THir) cells as a
DA neuron marker, and a significant reduc-
tion of cell number was found (27%). The
LPS treatment reduced the THir cells, but not
microtubule-associated protein-2 (MAP-2), a
marker of all neurons. The speciﬁcity of the
lesions and the timing of the inflammatory
response to LPS injection in the fetal brain
suggest that LPS might interfere with normal
DA neuron development. 
These results outline the possibility that,
after intrauterine infection, some individuals
may be born with limited striatal neurochemi-
cal reserves and a reduced DA cell count. This
reduced reserve might predispose adults to PD.
Perinatal infections may therefore represent
risk factors for PD. Most epidemiologic studies
on infection during early life and risk for PD
were conducted in England. A population-
based study was conducted in 42 general prac-
tices in eastern Hertfordshire (Martyn and
Osmond 1995). PD cases were subjects born
after 1910 and diagnosed by a neurologist or a
geriatrician, and controls were subjects in the
same general practices matched by age and sex
(172 cases, 343 controls). Records in the ﬁrst
part of the 20th century were used to obtain
information about birth weight and growth
during the first year of life. The subjects
answered a questionnaire about sibship, posi-
tion in the birth order, type of housing, other
features of the environment in early life, and
experience of the common infections of child-
hood. Subjects were more likely to have suf-
fered croup [odds ratio (OR) = 4.1; 95%
conﬁdence interval (CI), 1.1–16.1] or diphthe-
ria (OR = 2.3; 95% CI, 1.1–3.6). The results
of this study do not suggest that poor growth
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ogy of PD but do suggest that early infection
might have a role in susceptibility to PD. A
study conducted in a Harvard alumni cohort
showed a negative association between measles
infection and PD (Sasco and Paffenbarger
1985), and a reduced risk of PD was associated
with most childhood viral infections. The
authors speculate that a negative history of
measles could be a marker for negative
influenza history before 1918 and thus a
higher risk of infection during the 1918
inﬂuenza epidemic because of the lack of par-
tial influenza immunity. The data on infec-
tions in these studies were based on recall and
therefore should be interpreted with caution
(although a negative association in the
Harvard study is not what would be expected
in presence of recall bias).
Some investigators have examined the rela-
tionship between influenza pandemics and
PD, testing the hypothesis that PD could fol-
low intrauterine influenza (Mattock et al.
1988). Three groups of PD patients were iden-
tiﬁed through specialty clinics or general prac-
titioners. Matched controls were selected so
that they were born in the same 5-year period
as the index patient. For each group and each
calendar year, the ratio of parkinsonian to con-
trol births was calculated. This risk ratio was
used to estimate the relative risk of each cohort
developing PD in later life. Calendar years
with a PD:control ratio of 1.66 or greater were
defined as “cluster years.” Subjects born in
1892, 1904, 1909, 1918, 1919, and 1929
(years encompassing the inﬂuenza pandemics
of 1890–1930) appeared to have had an
increased risk of developing idiopathic PD
compared with subjects born in other periods,
and four of these years coincide with years of
influenza pandemic. The PD:control birth
ratio showed a signiﬁcant correlation with the
crude inﬂuenza mortality for the year of birth
during the period from 1900 to 1930
(Mattock et al. 1988). People born around
1900 had a risk of PD 5 times that of people
born around 1930 (Martyn 1997). A study
conducted in Aberdeen, Scotland, failed to
replicate these results (Ebmeier et al. 1989). A
cohort of 243 subjects with PD resident in
Aberdeen conﬁrmed a peak of PD births in the
year 1902, but there was no association
between PD births and inﬂuenza deaths. The
limited power of this cohort could be an expla-
nation for the negative results. The strong vari-
ation of PD risk from year to year of birth
shown in some of the previous studies would
be consistent with the action during develop-
ment of an infectious agent, more likely a virus
that typically occurs in epidemics.
Season or month of birth could be used as
surrogate of viral insult and has been associ-
ated with disorders such as schizophrenia
(Mortensen et al. 1999). Mattock et al.
(1988) reviewed the season of birth of
517 individuals with PD. They showed an
excess of births in the period between March
and June, with the greatest excess in May.
These results were confirmed in a study in
Japan on two different cohorts with an excess
of PD births in winter and spring (Miura
et al. 1987; Torrey et al. 2000).
All these studies were based on the
hypothesis that intrauterine influenza infec-
tion or other viral insults may be cytotoxic to
the developing fetal substantia nigra and could
enhance the risk of PD after a latent period
(Poskanzer and Schwab 1963; Takahashi and
Yamada 2001).
Data on the season of birth are some of
the least compelling arguments for a relation
between influenza and PD because there
are other potential variables that are charac-
terized by a seasonal variation that could be
responsible for the observed association.
Epidemiologic studies on the relationship
between infections early in life and PD are
deﬁnitively inconclusive.
Place of Birth
Geographic epidemiology is defined as a
description of the spatial pattern of disease
occurrence (Elliot et al. 1992). Place of birth
can be a surrogate for early-life exposure. State
of birth in the United States was studied as an
exposure of interest for PD (Betemps and
Buncher 1993). Outcome was measured by
death, using death certiﬁcates from U.S. death
information in 1981. The measure of effect was
the proportionate mortality ratio (PMR), using
all the other deaths in the United States as the
comparison group. Potential confounders such
as age, gender, and whether the state of birth
was the same as the state of death were included
in a logistic model. Cerebrovascular disease
deaths were used as a negative control group
because there is no association that is postulated
with childhood exposure; multiple sclerosis was
used as a positive control because it has been
found to be related to geography in childhood.
The results showed a very high PMR for Utah
(44.95/10,000), Idaho (37/10,000), Colorado
(31/10,000), New Mexico (32/10,000), Kansas
(32/10,000), and Nebraska (33/10,000), with a
west to east gradient. The lowest PMR was reg-
istered in Delaware (7.3/10,0000). However, it
is important to mention that PMR can be
affected by the distribution of other causes of
death. In contrast, a study conducted by
Kurtzke and Goldberg (1988) using death cer-
tiﬁcates showed that age-adjusted death rates of
PD presented a north–south gradient, similar
to that found for multiple sclerosis. In this
study only the state where the PD subject was
resident at the time of death was considered in
the analysis. Geographic studies based on death
certiﬁcates may be affected by the underreport-
ing of PD that can be inhomogeneous across
different geographic areas. Studies of geographic
variation need to be interpreted with caution
because many factors beyond environmental
exposure could determine the geographic pat-
tern of a disease. Genetic factors and ethnicity
are real sources of variation across different
regions beyond environmental exposure.
Chance, migration, differences in procedures
used to diagnose/classify cases, and access to
medical care are other possible alternative
explanations (Elliot et al. 1992).
Toxic Exposure Early in Life
The distinction between secondary parkinson-
ism and PD is critical, particularly when toxi-
cants are the exposure of interest. Therefore, in
this context, it is important to underscore that
the diagnosis of PD is clinical because no diag-
nostic biomarker is available. In every study on
PD there is some degree of misclassiﬁcation of
cases. In a recent population-based study the
initial diagnosis of PD was later conﬁrmed in
83% of 202 diagnosis but rejected in 15% of
the initial diagnosis (2% had diagnosis of pos-
sible PD; Schrag et al. 2002). The false-positive
diagnosis is generally due to vascular parkin-
sonism, essential tremor, drug-induced parkin-
sonism, or other neurodegenerative disorders
that include parkinsonism as one of the clinical
features, such as multisystem atrophy, progres-
sive sopranuclear palsy, and dementia. The use
of more stringent criteria causes the rate of false
positives to drop down to about 10% (Jellinger
2003). Missing the diagnosis of PD is particu-
larly frequent. Recent door-to-door epidemio-
logic studies show that almost one of four
prevalent cases of PD is detected during the
survey in the community (de Rijk et al. 1997).
The misclassification of cases if random and
not related to the exposure of interest makes
the detection of true association more difﬁcult
in analytic studies.
Clinical parkinsonism can be caused by a
series of exogenous factors such as viruses, toxic
substances such as MPTP and manganese, and
trauma. These clinical observations suggest
that environmental risk factors are important
for the etiology of PD. Several environmental
toxicants related to occupation in agriculture
have been implicated as risk factors in PD.
The chemical structure of 1-methyl-4-phenyl-
pyridinium (MPP+), the toxic metabolite of
MPTP, is similar to the herbicide paraquat
(PQ; Snyder and D’Amato 1985).
Animal experiments have clearly shown the
selective action of PQ on the DA system.
Systemic PQ given to mice through repeated
intraperitoneal injections induces selective dam-
age of DA neurons in the pars compacta of the
substantia nigra (McCormack et al. 2002). The
cell loss in this model was dependent on dose
and age. The presence of a different effect of the
exposure at different ages in this model outlines
a possible interaction of toxic environmental
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et al. 2002). Chronic, continuous, and systemic
exposure to rotenone, commonly used as an
insecticide in gardening, selectively inhibits
complex I, causing selective degeneration of the
nigrostriatal system with accumulation of cyto-
plasmic inclusions containing ubiquitin and
α-synuclein (Betarbet et al. 2000). In mice, PQ
exposure determines an up-regulation of
α synuclein, accelerating the formation of
aggregates in the substantia nigra (Manning-
Bog et al. 2002). This conﬁrms previous obser-
vations in vitro that postulated a selective
binding of PQ with partially folded α-synuclein
(Uversky et al. 2001).
Toxic exposures that occur early in develop-
ment could determine long-term pathology in
the central nervous system. A model exploring
this hypothesis should explore the possibility
that early damage to the DA system could
result in cell loss or high vulnerability to a sec-
ond environmental risk factor associated with
PD (two-hit model). A similar model was
hypothesized for exposure to PQ and the fungi-
cide maneb (MB) during development. The
combined action could permanently change the
nigrostriatal DA system and enhance its vulner-
ability to subsequent neurotoxicant challenges.
Mice exposed to two neurotoxicants, PQ and
MB, and subsequently exposed again as adults
presented with the most severe damage. They
showed a 70% reduction in motor activity
2 weeks after the last toxic dose (Thiruchelvam
et al. 2002). Developmental exposure to PQ or
MB alone produced minimal changes, whereas
a signiﬁcant decrease in nigral cell counts was
observed after adult exposure. Striatal DA levels
were reduced by 37% after only the develop-
mental exposure to PQ plus MB, but after a sec-
ond exposure during adulthood, striatal DA
levels were reduced by 62%. This experiment
suggests that the exposure during development
to the two toxicants produced a state of masked
toxicity that was revealed after adult re-exposure.
In another experiment conducted by the same
group, pregnant mice were treated with MB or
PQ (Barlow et al. 2004). Offspring were nor-
mal when evaluated on locomotor activity.
Subsequently offspring were treated with MB
or PQ. Only males treated with MB during the
prenatal period and with PQ during adulthood
showed a significant reduction of locomotor
activity (95%) and a selective DA loss in the
pars compact of the substantia nigra. Exposure
to speciﬁc pesticides during the prenatal period
can produce a limited but selective amount of
lesions in the nigrostriatal system. These devel-
opmental lesions might determine an enhanced
susceptibility that, in combination with later
exposure to other toxicants (PQ), may be
involved in the induction of PD during aging.
The results of experimental studies on the
role of pesticides are concordant with the
results of epidemiologic studies. A series of
epidemiologic studies have pointed out the
importance of pesticides, in particular insecti-
cides and fungicides. The problem with these
studies is that they were mainly case–control,
with a limited number of cases and without
biologic measurement of the exposure. Most of
the studies were based on retrospective collec-
tion of data with questionnaires (Checkoway
and Nelson 1999). The only prospective study
is the cohort study of Japanese men in Hawaii,
originally established for the investigation of
risk factors: 7,986 Japanese–American men
born between 1900 and 1919 were enrolled in
the longitudinal Honolulu Heart Program,
with a median length of follow-up of 27 years.
The relative risk of PD was 1.9 (95% CI,
1.0–3.5) for men who had worked more than
20 years on a plantation compared with men
who never worked in a plantation (sugarcane
and/or pineapple). The age-adjusted incidence
of PD was higher in men exposed to pesticides
than in men who never did plantation work
(Petrovitch et al. 2002).
A recent meta-analysis on environmental
risk factor and PD was performed using a large
number of studies (16 studies for living in rural
area, 18 studies for well water drinking,
11 studies for farming and 14 studies for pesti-
cides) (Priyadarshi et al. 2001). Restricting the
analysis to studies in the United States, the
combined OR was 1.44 (95% CI, 0.92–2.24)
for well water; 2.17 (95% CI, 1.54–3.06) for
rural residence; 1.72 (95% CI, 1.2–2.46) for
the combined exposure of living on a farm,
farming, and exposure to animals; and 2.26
(95% CI, 1.95–2.39) for exposure to pesti-
cides. The highest change in risk was for sub-
jects living in rural areas for more than 40 years
(OR = 4.9; 95% CI, 1.4–18.2). This might
indicate that a cumulative exposure over time
is needed but may also suggest that exposure
during early life is important. In a study con-
ducted in Saskatchewan, Canada, 20 of
22 cases of early-onset PD had exclusively rural
exposure and drank well water during the ﬁrst
15 years of life (Rajput et al. 1987). Well water
consumed in childhood could be considered a
potential vehicle for a toxic exposure. Analysis
of pesticides and of metals in the well water did
not reveal the role of any speciﬁc toxicant in
this Canadian study.
Neurotoxicants such as MB, rotenone, and
PQ interact with mitochondrial complex I
(Dawson and Dawson 2003). Reduced activity
of complex I has been described consistently in
PD subjects (Schapira et al. 1998). A possible
interaction between environmental risk factor
and genetic polymorphism in mitochondrial
genes and in genes involved in detoxiﬁcation of
metabolites has been intensively searched, with
inconsistent results (Tan et al. 2000). The
aggregation of α-synuclein and the subsequent
inhibition of proteasome could be the conse-
quence of complex I reduction in activity and
may determine the death of DA neurons. The
protection of proteasome function is one of
the hypothesized roles of parkin (Feany and
La Spada 2003).
Heterozygote mutations in the Parkin gene
have been associated with late-onset PD
(Oliveira et al. 2003). These parkin heterozy-
gote mutations or other mutations could act as
susceptibility genes in PD in conjunction with
environmental risk factors, including neuro-
toxicants. Combined treatment with the two
neurotoxicants PQ and Mn2+-ethylenebis-
dithiocarbamate shows enhanced toxicity only
in mice expressing human α-synuclein
(Thiruchelvam et al. 2004). Only a mutant
strain (hm2–α-Syn-39) presented enhanced
vulnerability to neurotoxicants. This specific
gene–environment interaction could be the
source of different responses to neurotoxicants
in different mice strains and in humans as well.
In conclusion, epidemiologic data suggest
that the use of pesticides or surrogates of pesti-
cide exposure increase the risk of PD. However,
no epidemiologic studies speciﬁcally address the
issue of toxic exposure early in life.
Coffee, Smoking, and
Personality Trait
In a recent meta-analysis, Hernan et al. (2002)
analyzed 44 case–control studies and 4 cohort
studies on smoking and 8 case–control studies
and 5 cohort studies on coffee drinking. The
risk of PD was 60% lower among smokers
than among nonsmokers and about 30% lower
in coffee drinkers than in non-coffee drinkers.
Smoking and coffee are complex exposures,
but the primary candidate substances for the
protective effects are nicotine and caffeine,
respectively. There is some evidence to support
a protective effect of caffeine on the DA sys-
tem. Mice treated with caffeine before expo-
sure to MPTP had reduced DA cell loss
compared with mice unexposed to caffeine
(Chen et al. 2001). The action of caffeine
seems to be mediated through a blocking
action on adenosine-2 receptors (Schwarzschild
et al. 2002). Similarly, in animal models, nico-
tine increases the presence of factors that have a
neuroprotective effect on DA neurons (Maggio
et al. 1998). Nicotine is an antioxidant (Ferger
et al. 1998) and is an inhibitor of monoamine
oxidase B that activates MPTP neuorotoxicity
(Yong and Perry 1986). Nevertheless, a differ-
ent biologic basis for these findings cannot
be excluded.
A premorbid personality in PD patients has
been described in several studies (Paulson and
Dadmehr 1991; Todes and Lees 1985).
Smoking and coffee drinking may be surrogates
of an underlying personality trait or behavior
and be related to a characteristic pre-parkinson-
ian personality (Marder and Logroscino 2002).
Smoking and coffee consumption generally
begin in early adulthood. Subjects who later
Logroscino
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ences that are associated with novelty or that are
socially inappropriate (Bharucha et al. 1986;
Ward et al. 1984). In a case–control study
conducted with data from the Rochester
Epidemiology Project, inverse associations were
reported between PD and tobacco chewing,
snuff use, and alcoholism (Benedetti et al.
2000). These exposures may represent patterns
of unusual behavior and may depend on the
presence of a speciﬁc personality trait.
Personality traits are established quite early
in life, and it is known that speciﬁc personality
traits are genetically related to the DA system
(Ebstein et al. 1996). Twin studies are useful
for trying to disentangle environmental and
genetic risk factors. In twins discordant for PD,
the twins who did not develop PD smoked
more than their twin (Tanner et al. 2002).
Interestingly, this effect was more pronounced
in monozygotic twins. The effect remained
even when the analysis was conducted 10 years
before the disease onset. This study suggests a
true biologic effect of smoking, but a further
effect of other traits that are present even
20 years before the disease onset cannot be
excluded. In a nested case–control study from
Kaiser Permanente on 626 subjects and
1,245 controls, Van Den Eeden et al. (2002)
classiﬁed subjects according to their personality
traits. The protective effect of smoking was
present even when restricting the analysis to
individuals who scored high for introversion
and depression. Among these subjects, smok-
ing reduced the risk of PD by 50%.
In the EUROPARKINSON Collaborative
Study, the protective effect of smoking was
present only in early-onset PD (onset before
age 50) but not in late-onset PD (Tzourio et al.
1997) Similar findings had been previously
reported in the Northern Manhattan Aging
Study in New York (Mayeux et al. 1994).
None of the previous studies looked at the
age when subjects began to smoke. In data
from the Nurses Health Study and the Health
Professional Study, subjects who started to
smoke early (before age 20) had a stronger
reduction in risk, independent of future
smoking behavior (A. Ascherio, personal
communication). This observation suggests
that if smoking is not causal, the other possi-
ble cause should already be present in the
causal pathway before age 20.
Again, many of these studies suggest that
the analysis of behavior in early adulthood
could be key to disentangling the role of
smoking, drinking coffee, and personality
traits on the occurrence of PD.
Familial Aggregation Studies
In early-onset PD, the mode of inheritance is
autosomal dominant or recessive (Golbe et al.
1990; Kitada et al. 1998). The role of genes
and the type of transmission are less clear for
late-onset PD. It is well known that subjects
with a family history of PD have an increased
risk of disease (Lazzarini et al. 1994; Marder
et al. 1996; Payami et al. 1994). Only a few
of these studies have been population based,
and none had complete genealogic informa-
tion. The population-based design is impor-
tant to avoid ascertainment bias because
relatives of subjects with the disease are more
likely to seek medical attention, and therefore
families with more than one family member
are more likely to be included. A recent study
from Iceland coupled the genealogic informa-
tion with a population-based study design
(Sveinbjornsdottir et al. 2000). In Iceland a
computerized database contains genealogic
information for 11 centuries, including infor-
mation on all the living Icelanders. PD cases
(772 patients) were identified from several
sources; 560 had late-onset PD. The risk ratio
for PD was 6.7 for siblings, 3.2 for offspring,
and 2.7 for nephews and nieces of patients
with late-onset PD. The authors concluded
that the pattern of inheritance was consistent
with both genetic and environmental factors.
In a subsequent comment on this study, it
was noticed that the risk ratio for siblings and
offspring was different, whereas the offspring
and nieces and nephews had similar risk (de la
Fuente-Fernandez and Calne 2001). This pat-
tern of inheritance was not consistent with
simple vertical or genetic clustering. These
data might be explained by the presence of
two birth cohorts (one for siblings and one
for offspring and nephews and nieces) that
had similar risk because of similar exposure in
the same period of their life to some environ-
mental risk factor. The results of the Icelandic
study support the idea that environmental
risk factors acting at different points in time
during the life span (including early life) are
critical for the development of PD.
There is evidence that some reported
familial cases may be due to environmental
factors. The age pattern within families with
multiple cases can help to determine if there
is a substantial involvement of environmental
risk factors over a specific period of time
(Calne et al. 1987). If an environmental expo-
sure is present, a similar time of onset should
be present in cases of the same family. If a
genetic effect is the main causal factor, then a
similar age of onset in different generations or
a pattern of age of onset is expected. In six
Canadian families with multiple cases, the
time interval between onset of symptoms
within the same family was relatively short
(1–8 years), whereas the mean difference in
age of onset of PD in children and parents in
this series was 25.2 years. Also, no correlation
was found between degree of consanguinity
and occurrence of disease. This report under-
scores the importance of environmental risk
factors in some of the familial PD cases.
In a case–control study conducted in Spain
with 299 PD patients and 295 controls, the
age of onset of PD was found to correlate with
maternal age at birth of the patient, but not
with paternal age. Both mothers and fathers
had increased risk of PD compared with par-
ents of controls (de la Fuente-Fernandez
2000). The author hypothesizes that environ-
mental exposure may cause mitochondrial
change in the mother that can then be trans-
mitted to the child through the ovum. In this
study, it is particularly interesting that the
negative correlation of PD age of onset with
maternal age was present also in PD probands
with an affected father. This study suggests
that environmental factors operating before
birth may have a role in PD, even if this does
not exclude the role of a genetic predisposition.
Conclusions
There is experimental evidence that PD and
other neurologic diseases related to aging may
have their origin during pregnancy or in early
life, including young adulthood. The epidemio-
logic studies exploring this hypothesis are few,
and the most were conducted many years ago.
Similar to that for cancer and cardiovascular
disease, the etiologic model for PD has explored
mainly risk factors associated with adult life or
in many cases after the age of 65 (Kuh and
Ben-Shlomo 1997). Cohort studies exploring
neurologic disease related to aging, with few
exceptions, are based on cohorts of subjects
65 or more years of age. The limitations of the
case–control approach when exploring ques-
tions on exposures that happened decades
before disease onset are well known.
The role of aging in the pathogenesis of
PD is not clear, but recent evidence suggests
that it is less important than was thought in
the past. In a recent neuropathologic study
there was no signiﬁcant loss of tyrosine hydrox-
ylase positive neurons in the substantia nigra in
normal subjects (44– 80 years of age). This
result suggests that normal aging is not accom-
panied by significant catecholaminergic cell
loss (Kubis et al. 2000). If these data are con-
ﬁrmed, it is conceivable that risk factors that
have a long latency or a slow effect could be
important for late-onset PD, independent
from a specific effect of aging. PD could be
“programmed” in utero according to the Barker
hypothesis for chronic diseases (Kuh and
Ben-Shlomo 1997), and aging may be only a
period where there is a second hit or an inter-
action with other processes. The risk factors in
early life could determine an increased risk for
PD, an earlier age of onset, or a different clini-
cal course. Testing these pathogenetic models
should be one of the future focuses of neuro-
epidemiologic research. To investigate the role
of neurodevelopment on neurodegeneration,
investigators must develop new methods to
characterize the early-life environment of the
Environment in early life and Parkinson disease
Environmental Health Perspectives • VOLUME 113 | NUMBER 9 | September 2005 1237Logroscino
1238 VOLUME 113 | NUMBER 9 | September 2005 • Environmental Health Perspectives
elderly. The alternative strategy is to build up
new cohorts or use existing cohorts that exam-
ine the whole life span, as in the Barker
approach to study cardiovascular diseases.
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